Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide Pharmacodynamics in C-IBS
NCT00258193Phase 2Completed
- Sponsor
- Ironwood Pharmaceuticals
- Start
- Jan 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of linaclotide in irritable bowel syndrome (IBS), sponsored by Ironwood Pharmaceuticals. Started Jan 2006; status: completed.
02
Drugs
linaclotide
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00258193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00258193.